ANNUAL REPORT

Company

Niagen Bioscience, Inc.

Filed

March 17, 2016

Period of Report

January 2, 2016

Accession Number

0001415889-16-005140

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →